Filter posts

Blaming Pharma Won’t Lower Health Care Costs

This week, the USA Today Editorial Board took aim at the pharmaceutical industry in a new piece: Stop …

#BIF17: Looking Ahead to 2018 Policy Landscape

The past year has seen a number of important changes in the legislative and policy …

#BIF17: Turning the Tide on Antimicrobial Resistance

It’s no secret that antimicrobial resistance (AMR) is one of the most serious public health …

For Today’s Hearing on the Drug Delivery System, ‘Follow The Pill’

The Senate Committee on Health, Education, Labor, and Pensions will hold a hearing this morning …

New Infographic: The Bayh-Dole Act

$1.3 trillion in economic output. Support for roughly 4.2 million jobs. The creation of more …

ICYMI: Jim Greenwood Weighs In on the Future of Drug Pricing

Rewarding for quality – not quantity – is becoming more and more common in health …

ICYMI: Drug Development is Complicated. Let’s Start with the Facts.

Here’s a fact you might not have known: 90% of drug development programs fail. Yet …

Challenges and Opportunities in Personalized Medicine

Last week the sixth annual Patient and Health Advocacy Summit brought hundreds of patient advocates, …

ICYMI: Hope and Cures for Africa

For individuals and families across the globe, what were once considered deadly or debilitating diseases …

Patient and Industry Collaboration: Key to Successful Clinical Trials?

During the BIO Patient & Health Advocacy Summit last week, a panel led by Julie …